Selpercatinib (LOXO-292) in patients with RET-Fusion+ non small-cell lung cancer(NSCLC)

This article has no abstract
Epistemonikos ID: a251e4e2df1833482d8be3a203de9b02e86f3d27
First added on: Feb 12, 2025